Panjon Ltd
₹ 20.2
2.90%
25 Aug
4:01 p.m.
About
Incorporated in 1983, Panjon Ltd manufactures and trades in consumers and pharmaceutical
products[1]
Key Points
- Market Cap ₹ 34.7 Cr.
- Current Price ₹ 20.2
- High / Low ₹ 30.0 / 16.1
- Stock P/E 56.9
- Book Value ₹ 9.93
- Dividend Yield 0.00 %
- ROCE 4.87 %
- ROE 3.57 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 133 days to 77.0 days
Cons
- Company has a low return on equity of 2.46% over last 3 years.
- Earnings include an other income of Rs.0.33 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.47 | 12.26 | 13.98 | 20.10 | 25.94 | 26.43 | 14.49 | 8.41 | 6.09 | 12.55 | 30.46 | 47.62 | 49.28 | |
| 22.54 | 12.35 | 14.00 | 19.68 | 25.63 | 26.11 | 14.30 | 12.45 | 6.09 | 12.57 | 29.83 | 46.64 | 48.30 | |
| Operating Profit | -3.07 | -0.09 | -0.02 | 0.42 | 0.31 | 0.32 | 0.19 | -4.04 | 0.00 | -0.02 | 0.63 | 0.98 | 0.98 |
| OPM % | -15.77% | -0.73% | -0.14% | 2.09% | 1.20% | 1.21% | 1.31% | -48.04% | 0.00% | -0.16% | 2.07% | 2.06% | 1.99% |
| -1.51 | 0.43 | 0.52 | 0.21 | 0.36 | 0.29 | 0.33 | 0.30 | 0.38 | 0.45 | 0.31 | 0.30 | 0.33 | |
| Interest | 0.00 | 0.17 | 0.19 | 0.28 | 0.24 | 0.15 | 0.10 | 0.07 | 0.05 | 0.06 | 0.18 | 0.27 | 0.29 |
| Depreciation | 0.13 | 0.14 | 0.13 | 0.11 | 0.15 | 0.27 | 0.23 | 0.20 | 0.21 | 0.22 | 0.23 | 0.30 | 0.30 |
| Profit before tax | -4.71 | 0.03 | 0.18 | 0.24 | 0.28 | 0.19 | 0.19 | -4.01 | 0.12 | 0.15 | 0.53 | 0.71 | 0.72 |
| Tax % | -27.18% | -1,133.33% | 33.33% | 50.00% | 53.57% | 115.79% | 47.37% | 3.49% | -575.00% | 0.00% | 24.53% | 15.49% | |
| -3.43 | 0.36 | 0.12 | 0.12 | 0.14 | -0.03 | 0.10 | -4.15 | 0.81 | 0.15 | 0.40 | 0.60 | 0.61 | |
| EPS in Rs | -2.21 | 0.23 | 0.08 | 0.08 | 0.09 | -0.02 | 0.06 | -2.68 | 0.52 | 0.09 | 0.23 | 0.35 | 0.35 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 27% |
| 3 Years: | 98% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 43% |
| 3 Years: | -10% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| 1 Year: | 13% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -3% |
| 3 Years: | 2% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 16.31 | 17.17 | 17.17 |
| Reserves | 0.52 | 0.89 | 1.00 | 1.13 | 1.27 | 1.23 | 1.31 | -2.84 | -2.02 | -1.46 | -0.62 | -0.13 |
| 1.52 | 1.41 | 1.26 | 1.89 | 1.84 | 1.56 | 1.33 | 0.81 | 0.78 | 1.44 | 2.65 | 4.01 | |
| 0.51 | 0.24 | 0.28 | 0.29 | 0.34 | 0.92 | 1.12 | 0.58 | 0.64 | 1.10 | 0.85 | 0.71 | |
| Total Liabilities | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 | 21.76 |
| 0.92 | 0.84 | 0.74 | 0.72 | 0.87 | 1.12 | 0.96 | 0.95 | 0.91 | 0.90 | 1.09 | 1.44 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.08 | 1.07 | 1.07 | 1.08 | 1.08 | 1.10 | 1.11 |
| 16.05 | 16.12 | 16.22 | 17.00 | 16.99 | 17.01 | 17.23 | 12.03 | 12.91 | 15.41 | 17.86 | 19.21 | |
| Total Assets | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 | 21.76 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.89 | -0.20 | 0.18 | -0.17 | 0.49 | 0.35 | 0.34 | 1.82 | 0.04 | -0.42 | -4.34 | -0.43 | |
| 4.74 | -0.06 | -0.04 | -0.08 | -0.31 | -0.51 | -0.06 | -0.19 | -0.19 | -0.21 | -0.44 | -0.66 | |
| -5.14 | -0.19 | -0.17 | 0.40 | -0.05 | -0.07 | -0.24 | -0.51 | 0.18 | 1.88 | 2.50 | 1.38 | |
| Net Cash Flow | 0.49 | -0.44 | -0.03 | 0.15 | 0.13 | -0.22 | 0.04 | 1.12 | 0.04 | 1.25 | -2.27 | 0.28 |
| Free Cash Flow | 5.54 | -0.26 | 0.14 | -0.25 | 0.18 | -0.17 | 0.27 | 1.63 | -0.14 | -0.62 | -4.76 | -1.08 |
| CFO/OP | -29% | 222% | -1,100% | -29% | 177% | 122% | 195% | -45% | 2,000% | -689% | -33% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184.28 | 261.39 | 21.67 | 16.89 | 23.64 | 45.57 | 93.45 | 26.47 | 93.50 | 52.64 | 39.06 | 41.93 |
| Inventory Days | 46.16 | 101.43 | 95.13 | 66.63 | 57.65 | 59.10 | 120.11 | 306.47 | 610.67 | 152.35 | 65.87 | 48.45 |
| Days Payable | 7.20 | 4.14 | 2.93 | 2.19 | 3.98 | 11.48 | 28.24 | 19.51 | 63.17 | 6.93 | 3.56 | 2.83 |
| Cash Conversion Cycle | 223.24 | 358.68 | 113.87 | 81.33 | 77.31 | 93.20 | 185.32 | 313.43 | 641.00 | 198.07 | 101.37 | 87.54 |
| Working Capital Days | 262.83 | 428.41 | 177.80 | 123.85 | 112.85 | 138.51 | 261.22 | 277.76 | 480.07 | 216.38 | 105.45 | 77.03 |
| ROCE % | -14.51% | 1.13% | 2.08% | 2.87% | 2.80% | 1.84% | 1.59% | -24.93% | 1.23% | 1.37% | 4.00% | 4.87% |
Insights
In beta| Mar 2016 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Total equity shares outstanding shares |
|
||||||
| Number of permanent employees on rolls count |
|||||||
| Trading segment revenue share of total revenue percent |
|||||||
| Central region revenue share of total revenue percent |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Enclosed herewith Newspaper Publication for Quarter ended 30-06-2026
-
Un-Audited Financial Result For Quarter Ended 30-06-2026
- Board approved Q1 FY27 results, appointed Archit Kothari, and fixed 30 September 2026 AGM.
-
Board Meeting Outcome for Board Meeting Dated 13/08/2026
- Panjon approved Q1 FY2026 results, appointed Archit Kothari as additional director, and fixed AGM on 30 September 2026.
-
Board Meeting Intimation for Board Meeting Dated 13/08/2026
- Board meets on 13 August 2026 to approve Q1 FY27 unaudited results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended 30 June 2026.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2011
from bse
-
Annual Report 2010
from bse
Business Overview:[1][2]
a) Panjon is in the business of specialized Medicinal, Digestive, Ayurvedic & Confectionary products
b) Presently, the company is mainly into reality development
c) The company, considering the slowdown in the reality sector and considering the experiences of the promoters, has started the trading business of Petroleum product. The turnover is mainly
from the trading activities of the petroleum products.
d) The company also started venturing into
the waste management activities of medical
bi-products.